Qiagen FY26 H1 net income drops 30.94% to $122.84 million; net sales rise 1% to $1.03 billion
QGEN•Margins narrow as other financial results worsen
Operating income slipped 5% to USD 216.85 million; operating margin narrowed 1.3 percentage points to 21.1%.
Other financial results worsened to a USD 51.34 million loss, reflecting USD 60.9 million in fair-value changes in warrants and embedded conversion options.
Net cash from operating activities edged up to USD 321.68 million; management cited higher Parse-related costs, tariffs and currency moves, partly offset by restructuring gains.
Qiagen reports higher sales but lower profit in FY26 H1
Qiagen posted net income of USD 122.84 million, down 31% for the six months ended June 30, 2026.
Net sales rose 1% to USD 1.03 billion, with consumables up 2% to USD 928.3 million while instruments fell 6% to USD 99.1 million.
